Washington Sales Clemente
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Washington Sales Clemente has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Priscilla Karilline Do Vale Bezerra
Postgraduate Program in Pharmaceutical Services and Policies, Health Science Center, Federal University of Rio Grande do Norte , Natal, RN 59078-970
1 shared publication - Rand Randall Martins
Universidade Federal do Rio Grande do Norte, Brasil
1 shared publication - Tatiana Xavier da Costa
Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil
1 shared publication - Thiago de Lima Pessoa
Universidade Federal do Rio Grande do Norte, Brazil
1 shared publication
Latest Publications
- Open Access
- 22 May 2019
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 17 (3) , eAO4521
Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensive care unit. Clinical data were collected and severe potential drug interactions were identified on pregnant inpatients. The drug interactions were classified by type, prevalence and exposure rate. A multivariate logistic regression model was used to identify the severe potential drug interactions and the related drugs (p<0.05). A total of 95.1% of patients were exposed to, at least, one potential drug interaction; in that, 91.7% 33.9% were related to, respectively, moderate and severe potential drug interactions. The patients were exposed, on average, on 69.2% of days they were in the intensive care unit. The main drugs involved in more severe drug interactions were magnesium sulfate, metoclopramide, propranolol and diazepam. The severe potential drug interactions were observed in almost all patients of the study, and, approximately one third of those interactions were related to greater severity and resulted in exposure during long hospital stay. The higher number of prescribed drugs and its previous use of medications at home increase the occurrence of severe potential drug interactions.
- 22 May 2019
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 17 (3) , eAO4521
Open AccessDrug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensive care unit. Clinical data were collected and severe potential drug interactions were identified on pregnant inpatients. The drug interactions were classified by type, prevalence and exposure rate. A multivariate logistic regression model was used to identify the severe potential drug interactions and the related drugs (p<0.05). A total of 95.1% of patients were exposed to, at least, one potential drug interaction; in that, 91.7% 33.9% were related to, respectively, moderate and severe potential drug interactions. The patients were exposed, on average, on 69.2% of days they were in the intensive care unit. The main drugs involved in more severe drug interactions were magnesium sulfate, metoclopramide, propranolol and diazepam. The severe potential drug interactions were observed in almost all patients of the study, and, approximately one third of those interactions were related to greater severity and resulted in exposure during long hospital stay. The higher number of prescribed drugs and its previous use of medications at home increase the occurrence of severe potential drug interactions.